NCT00021294View on ClinicalTrials.gov

Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2001

Primary Completion Date

June 30, 2002

Study Completion Date

June 30, 2002

Conditions
Non-melanomatous Skin CancerPrecancerous/Nonmalignant Condition
Interventions
DRUG

eflornithine

DRUG

triamcinolone

Trial Locations (1)

85724

Arizona Cancer Center, Tucson

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Arizona

OTHER

NCT00021294 - Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis | Biotech Hunter | Biotech Hunter